Dawnzera (donidalorsen) effects and efficacy

Dawnzera (donidalorsen) is an innovative medicine specifically designed to prevent hereditary angioedema (HAE) attacks. Its active ingredient, donidalorsen, is an ASO-GalNAc conjugate. This drug plays an important therapeutic role in HAE patients through a unique mechanism. The main mechanism of action of Dawnzera is by binding to prokallikrein (PKK) mRNA to promote H1 ribonuclease (RNase H1)-mediated degradation, thereby reducing the production of PKK protein. PKK is the precursor of plasma kallikrein, and its excessive activity is closely related to the onset of HAE.

The common pathophysiological mechanism in patients with HAE is due to the lack or dysfunction of C1 esterase inhibitor (C1-INH), which leads to an abnormal increase in kallikrein activity in plasma, which in turn causes the production of a large amount of bradykinin. Bradykinin is a powerful vasodilator. Its excessive release can lead to increased vascular permeability, thereby causing angioedema and severe pain, which brings great trouble to patients' lives.

By reducingPKK concentration, Dawnzera effectively blocks the overproduction of bradykinin. This mechanism can not only reduce the frequency of HAE attacks, but also reduce the symptoms and pain experienced by patients during attacks. Clinical studies have shown that Dawnzera has significant efficacy in treating HAE, which can improve patients' quality of life to a certain extent and help patients better control the disease.

In addition,Dawnzera is administered by subcutaneous injection, and the dosage schedule in clinical studies is 80mg every 4 weeks. This dosage frequency design allows patients to maintain the effective concentration of the drug during treatment and ensures its sustained preventive effect. Patients only need to perform self-injections under the guidance of a doctor, which allows them to manage their condition more conveniently and reduce the inconvenience caused by frequent medical visits.

Reference materials:https://www.drugs.com/dawnzera.html